Literature DB >> 17926129

Basic concepts and recent developments in human steroid hormone biosynthesis.

Hans K Ghayee1, Richard J Auchus.   

Abstract

The biosynthesis of steroid hormones requires the coordinated expression of the enzymes that comprise the pathways via which specific hormones are synthesized. These pathways and their associated enzymes are typically subject to regulation consisting of trophic hormone stimuli and feedback mechanisms. Very few tissues contribute substantially to de novo steroidogenesis, primarily the adrenal glands, the gonads, and the placenta. Both the embryonic origins and the signaling mechanisms for the adrenals and gonads are similar, and steroid synthesis in these two glands are the major focus of this review. We will further describe peripheral steroid metabolism and the regulation of steroid hormone potency in target tissues. In addition, we will briefly discuss the congenital adrenal hyperplasias to illustrate the principles developed in the initial sections. Finally, we will discuss some recent developments in steroidogensis, focusing on cytochrome P450 oxidoreductase deficiency and the alternate or "backdoor" pathway to dihydrotestosterone. We will conclude with a description of aberrant signaling mechanisms observed in adrenal tumors as a further example of how these pathways can be disturbed in pathologic states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926129     DOI: 10.1007/s11154-007-9052-2

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  70 in total

1.  The aldo-keto reductase (AKR) superfamily: an update.

Authors:  J M Jez; T M Penning
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

2.  Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.

Authors:  A Lacroix; E Bolté; J Tremblay; J Dupré; P Poitras; H Fournier; J Garon; D Garrel; F Bayard; R Taillefer
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

Review 3.  Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis.

Authors:  E R Simpson
Journal:  Mol Cell Endocrinol       Date:  1979-03       Impact factor: 4.102

4.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

5.  Molecular symmetry of glyceraldehyde-3-phosphate dehydrogenase.

Authors:  M G Rossmann; G C Ford; H C Watson; L J Banaszak
Journal:  J Mol Biol       Date:  1972-02-28       Impact factor: 5.469

6.  Expression profiles for steroidogenic enzymes in adrenocortical disease.

Authors:  Mary H Bassett; Bobbie Mayhew; Khurram Rehman; Perrin C White; Franco Mantero; Giorgio Arnaldi; Paul M Stewart; Iwona Bujalska; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

Review 7.  Cushing's syndrome variants secondary to aberrant hormone receptors.

Authors:  André Lacroix; Valérie Baldacchino; Isabelle Bourdeau; Pavel Hamet; Johanne Tremblay
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

8.  Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.

Authors:  E Rhéaume; Y Lachance; H F Zhao; N Breton; M Dumont; Y de Launoit; C Trudel; V Luu-The; J Simard; F Labrie
Journal:  Mol Endocrinol       Date:  1991-08

9.  Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.

Authors:  Chantal Lutfallah; Weihua Wang; J Ian Mason; Ying Tai Chang; Anzar Haider; Barry Rich; Mariano Castro-Magana; Kenneth C Copeland; Raphael David; Songya Pang
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.

Authors:  E Rhéaume; J Simard; Y Morel; F Mebarki; M Zachmann; M G Forest; M I New; F Labrie
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

View more
  48 in total

Review 1.  The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer.

Authors:  Nima Sharifi
Journal:  J Investig Med       Date:  2012-02       Impact factor: 2.895

2.  Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.

Authors:  Steve Seung-Young Lee; Junjie Li; Jien Nee Tai; Timothy L Ratliff; Kinam Park; Ji-Xin Cheng
Journal:  ACS Nano       Date:  2015-02-16       Impact factor: 15.881

3.  The ferrous-oxy complex of human aromatase.

Authors:  Yelena V Grinkova; Ilia G Denisov; Michael R Waterman; Miharu Arase; Norio Kagawa; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2008-05-13       Impact factor: 3.575

4.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

5.  Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression.

Authors:  Natasha C Lucki; Sibali Bandyopadhyay; Elaine Wang; Alfred H Merrill; Marion B Sewer
Journal:  Mol Endocrinol       Date:  2012-01-19

Review 6.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

Review 7.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.

Authors:  Erin K Shanle; Wei Xu
Journal:  Chem Res Toxicol       Date:  2010-11-05       Impact factor: 3.739

8.  The effects of di-2-ethylhexyl phthalate on testicular ultrastructure and hormone-regulated gene expression in male rats.

Authors:  Xiaoyun Qin; Quan Ma; Jianhui Yuan; Xinnan Hu; Qin Tan; Zena Zhang; Li Wang; Xinyun Xu
Journal:  Toxicol Res (Camb)       Date:  2018-02-02       Impact factor: 3.524

Review 9.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

10.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.